ARETAEUS Sàrl

ARETAEUS Sàrl, limited liability company in Genève (GE). Registration active in the commercial register. Latest publication: July 31, 2020. UID CHE-100.475.042.

Aretaeus is dedicated to the discovery and development of new medicines for Type I and Type II diabetes mellitus and obesity. It also explores solutions for male genitourinary disorders and offers medical oversight for bio-pharmaceutical companies.¹

Commercial register

Legal form: Limited liability company Sàrl/GmbH
Registered office: Plateau de Champel 34, 1206 Genève
Share capital: CHF 20,000
UID: CHE-100.475.042
Registered purpose (original language): conseil, formation, et la communication dans les domaines pharmaceutiques et médicaux.

All 7 companies registered at this address

Similar companies

Adipogen SA Epalinges
ADOBES Sàrl Prilly Human health activities
AB2 Bio SA Ecublens (VD) Manufacture of basic pharmaceutical products
Abbott Finance Company SA Fribourg
Atreon SA Pully Scientific research and development
Ferring Holding S.A. Saint-Prex Financial service activities, except insurance and pension funding

A free account opens every company that looks like ARETAEUS Sàrl, and what they have in common. Create a free account

Register publications

The commercial register publishes each notice only in the language of the registry office concerned, and Prospex reproduces it unchanged.

Address changed July 31, 2020

ARETAEUS Sàrl, à Genève, CHE-100.475.042 (FOSC du 19.12.2013, p. 0/7225832). Nouvelle adresse suite à nouvelle dénomination par la commune: Plateau de Champel 34, 1206 Genève.

Source: Swiss Official Gazette of Commerce (FOSC).

¹ This information was estimated by machine learning and may contain errors.